| 08/11/2026 3:51 PM | Cain Wettan Keeley M (2110603) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 4:04 PM | Gilead Sciences (882095) Filer | Form S-3ASR | |
| 08/04/2026 4:40 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2026 3:03 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/03/2026 3:41 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/16/2026 5:08 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/16/2026 3:54 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2026 3:10 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/15/2026 3:13 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/16/2026 4:53 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 5:02 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for GILD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/15/2026 3:30 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/11/2026 5:29 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 5:31 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 5:32 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 5:34 PM | Cain Wettan Keeley M (2110603) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 5:35 PM | Berger Dietmar (1739515) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 5:04 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 3:45 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/27/2026 7:55 PM | ASSEMBLY BIOSCIENCES, INC. (1426800) Issuer Gilead Sciences (882095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 7:51 PM | ASSEMBLY BIOSCIENCES, INC. (1426800) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D/A | |
| 05/20/2026 3:15 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 4:45 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 4:50 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:15 PM | Gilead Sciences (882095) Filer | Form 424B5 | |
| 05/14/2026 4:11 PM | Gilead Sciences (882095) Subject | Form FWP | |
| 05/14/2026 7:46 AM | Gilead Sciences (882095) Filer | Form 424B5 | |
| 05/08/2026 4:00 PM | Gilead Sciences (882095) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/07/2026 4:12 PM | Gilead Sciences (882095) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 4:13 PM | Gilead Sciences (882095) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/07/2026 3:03 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 3:31 PM | Gilead Sciences (882095) Issuer Horning Sandra (1638709) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:36 PM | BARTON JACQUELINE K (1183680) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:19 PM | Gilead Sciences (882095) Issuer Kramer Kelly A. (1629885) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:20 PM | Gilead Sciences (882095) Issuer MANWANI HARISH (1527726) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:05 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 5:41 PM | Gilead Sciences (882095) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 4:53 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/28/2026 8:13 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D/A | |
| 04/28/2026 7:53 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-T/A | |
| 04/28/2026 7:56 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
The end may be near for these iconic stocks (Ad) Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
| 04/17/2026 8:00 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-T/A | |
| 04/16/2026 5:40 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 5:41 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:12 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/15/2026 3:08 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/01/2026 3:34 PM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-T/A | |
| 03/30/2026 4:59 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 3:03 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 5:40 PM | Gilead Sciences (882095) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/17/2026 5:56 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 5:14 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/12/2026 3:45 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/12/2026 3:24 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:46 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 1:49 PM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-C | |
| 02/23/2026 5:46 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 5:48 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-C | |
| 02/23/2026 5:51 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D | |
| 02/18/2026 4:11 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 4:31 PM | Gilead Sciences (882095) Reporting Xilio Therapeutics, Inc. (1840233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 6:26 PM | Cain Wettan Keeley M (2110603) Reporting Gilead Sciences (882095) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/06/2026 3:22 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:49 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:51 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:46 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 12:23 PM | FMR LLC (315066) Filed by Gilead Sciences (882095) Subject | Form SCHEDULE 13G | |
| 01/29/2026 4:23 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 6:29 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 3:03 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/22/2026 3:32 PM | Gilead Sciences (882095) Subject Telman Deborah H (1860008) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/21/2026 3:26 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 3:01 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/16/2026 5:10 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/16/2026 5:18 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 3:01 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/15/2026 3:02 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/05/2026 4:56 PM | Berger Dietmar (1739515) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/30/2025 3:23 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 5:31 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 5:12 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:04 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 3:04 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/11/2025 7:38 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 7:40 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 5:25 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 5:11 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 3:36 PM | Gilead Sciences (882095) Reporting Xilio Therapeutics, Inc. (1840233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/28/2025 12:02 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/28/2025 12:05 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/26/2025 3:16 PM | Gilead Sciences (882095) Subject Kramer Kelly A. (1629885) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free |
| 11/19/2025 7:30 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/18/2025 6:00 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 5:51 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 3:05 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/17/2025 3:06 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/13/2025 6:36 PM | Gilead Sciences (882095) Issuer Telman Deborah H (1860008) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 4:07 PM | Gilead Sciences (882095) Subject Wilfong Diane E. (1374988) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/13/2025 3:44 PM | Gilead Sciences (882095) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 11/05/2025 4:19 PM | Arcus Biosciences, Inc. (1724521) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D/A | |